SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $6,588,000 | +55.9% | 40,084 | +9.3% | 0.02% | +38.5% |
Q1 2020 | $4,226,000 | -65.2% | 36,659 | -65.5% | 0.01% | -56.7% |
Q4 2019 | $12,129,000 | +150.9% | 106,189 | +66.9% | 0.03% | +114.3% |
Q3 2019 | $4,835,000 | +50.6% | 63,617 | +37.2% | 0.01% | +55.6% |
Q2 2019 | $3,210,000 | -25.9% | 46,374 | -21.6% | 0.01% | -25.0% |
Q1 2019 | $4,334,000 | +97.6% | 59,181 | +50.7% | 0.01% | +100.0% |
Q4 2018 | $2,193,000 | -2.9% | 39,279 | +34.1% | 0.01% | +20.0% |
Q3 2018 | $2,258,000 | +116.7% | 29,283 | +47.2% | 0.01% | +150.0% |
Q2 2018 | $1,042,000 | 0.0% | 19,900 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,042,000 | -64.2% | 19,900 | -63.4% | 0.00% | -80.0% |
Q4 2017 | $2,911,000 | +18.7% | 54,400 | +18.1% | 0.01% | -9.1% |
Q2 2017 | $2,453,000 | +4.2% | 46,064 | +3.3% | 0.01% | 0.0% |
Q4 2016 | $2,354,000 | -46.8% | 44,600 | -46.3% | 0.01% | -45.0% |
Q3 2016 | $4,428,000 | +44.9% | 83,100 | +9.8% | 0.02% | +17.6% |
Q2 2016 | $3,055,000 | – | 75,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |